Biochemical and molecular biological studies on oral cancer: An overview

Open Nutraceuticals Journal

Volumn 4, Issue , 2011, Pages 180-188

  Srivastava, Rashi ^a,b   Sharma, Rolee ^b   Mishra, Sanjay ^a,c   Singh, R B ^d  

^a IFTM   (India)

^b INTEGRAL UNIVERSITY   (India)

^c Department of Biotechnology and College of Engineering and Technology ^*  (India)

^d Halberg Hospital and Research Center   (India)

Author keywords

Computational biotechnology of oral carcinoma; Neoplasia; Nutraceuticals; Oncogenes; Oral cancer; Papillomavirus

Indexed keywords

ANTINEOPLASTIC AGENT; DITHIOTHREITOL; DNA; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; IODOACETAMIDE; MERCAPTOETHANOL;

ALCOHOL CONSUMPTION; BIOCHEMISTRY; CANCER RADIOTHERAPY; CANCER RESEARCH; CARCINOGENESIS; CHROMOSOME ABERRATION; CIGARETTE SMOKING; DISEASE ASSOCIATION; GAIN OF FUNCTION MUTATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GST GENE; GSTM1 GENE; GSTT1 GENE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MALIGNANT TRANSFORMATION; MOLECULAR BIOLOGY; MOUTH CANCER; ONCOGENE; ONCOGENE RAS; ORAL SURGERY; POPULATION GENETICS; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW; RISK FACTOR; TUMOR SUPPRESSOR GENE;

HUMAN PAPILLOMAVIRUS; NICOTIANA TABACUM; PAPILLOMAVIRIDAE;

EID: 80055114235     PISSN: None     EISSN: 18763960     Source Type: Journal    
DOI: 10.2174/1876396001104010180     Document Type: Review

References (49)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993; 54: 594-606.
2. Coleman MP, Esteve J, Damiecki P, Arslan A, Renard H. Trends in Cancer Incidence and Mortality. IARC Scientific Publications No. 121, IARC, Lyon, 1993.
3. Indian Council of Medical Research (19922) National Cancer Registry Programme: Biennial Report 1988-1989. ICMR, New Delhi, India.
4. Parkin DM, Whelan SL, Ferlay J, Raymond LA, Young J. Cancer Incidence in Five Continents Vol. VII. IARC Scientific Publications No. 143, IARC, Lyon, 1997.
5. Macfarlane GJ, Boyle P, Evstifeeva TV, Robertson C, Scully C. (1994) Rising trends of oral cancer mortality among males worldwide: the return of an old public health problem. Cancer Causes Control 1994; 5(3): 259-65.
6. La Vecchia C, Tavani A, Franceschi S, Levi F, Corrao G, Negri E. Epidemiology and prevention of oral cancer. Oral Oncol 1997; 33: 302-12.
7. IARC Tobacco smoking. In IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 38. IARC Scientific Publications, Lyon, 1986.
8. Hoffmann D, Hecht SS. (1985) Nicotine-derived N-nitrosamines and tobacco-related cancer: current status and future directions. Cancer Res 1985; 45: 935-44.
9. Nair UJ, Nair J, Friesen MD, Bartsch H, Ohshima H. Orthoand meta-tyrosine formation from phenylalanine in human saliva as a marker of hydroxyl radical generation during betel quid chewing. Carcinogenesis 1995; 16: 1195-8.
10. Mishra S, Singh RB, Dwivedi SP, et al. Effect of nutraceuticals on genetic expressions. Open Nutra J 2009; 2: 70-80.
11. Nair UJ, Obe G, Friesen M, Goldberg MT, Bartsch H. Role of lime in the generation of reactive oxygen species from betel-quid ingredients. Environ Health Perspect 1992; 98: 203-5.
12. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995; 30: 445-600.
13. Brockmöller J, Kerb R, Drakoulis N, Staffeldt B, Roots I. (1994) Glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility: a case-control study. Cancer Res 1994; 54: 4103-11.
14. Chenevix TG, Young J, Coggan M, Board P. Glutathione Stransferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset. Carcinogenesis 1995; 16: 1655-7.
15. Hayashi S, Watanabe J, Kawajiri K. High susceptibility to lung cancer analyzed in terms of combined genotypes of P4501A1 and Muclass glutathione S-transferase genes. Japn J Cancer Res 1992; 83: 866-70.
16. Katoh T, Nagata N, Kuroda Y, et al. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis 1996; 17: 1855-9.
17. Lafuente A, Pujol F, Carretero P, Villa JP, Cuchi A. Human Glutathione S-transferase mu (GST mu) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers. Cancer Lett 1993; 68: 49-54.
18. Elexpuru CJ, Buxton N, Kandula V, et al. Susceptibility to astrocytoma and meningioma: influence of allelism at glutathione Stransferase(GSTT1 and GSTM1) and cytochrome P-450 (CYP2D6) loci. Cancer Res 1995; 55: 4237-9.
19. Rebbeck TR. Molecular epidemiology of the human glutathione Stransferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1997; 6: 733-43.
20. Board P, Coggan M, Johnston P, Ross V, Suzuki T, Webb G. Genetic heterogeneity of the human glutathione transferases: a complex of gene families. Pharmacol Ther 1990; 48: 357-69.
21. Chenevix TG, Young J, Coggan M, Board P. Glutathione Stransferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset. Carcinogenesis 1995; 16: 1655-7.
22. Elexpuru CJ, Buxton N, Kandula V, et al. Susceptibility to astrocytoma and meningioma: influence of allelism at glutathione Stransferase (GSTT1 and GSTM1) and cytochrome P-450 (CYP2D6) loci. Cancer Res 1995; 55: 4237-9.
23. Nelson HH, Wiencke JK, Christiani DC, et al. Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis 1995; 16: 1243-5.
24. Lee EJ, Wong JY, Yeoh PN, Gong NH. Glutathione Stransferasetheta (GSTT1) genetic polymorphism among Chinese, Malays and Indians in Singapore. Pharmacogenetics 1995; 5: 332-4.
25. Muller FL, Lustgarten MS, Jang Y, Richardson A, Van Remmen H. Trends in oxidative aging theories. Free Radic Biol Med 2007; 43(4): 477-503.
26. Meister A. Glutathione metabolism and its selective modification. J Biol Chem 1988; 263(33): 17205-8.
27. Mannervik B. The enzymes of glutathione metabolism: an overview. Biochem Soc Trans 1987; 15(4): 717-8.
28. Kanzok SM, Fechner A, Bauer H, et al. Substitution of the thioredoxin system for glutathione reductase in Drosophila melanogaster. Science 2001; 291(5504): 643-6.
29. Champe PC, Harvey RA, Ferrier DR. Biochemistry, Fourth Edition. Lippincott Williams and Wilkins, 2008.
30. Marty L, Siala W, Schwarzländer M, et al. The NADPH-dependent thioredoxin system constitutes a functional backup for cytosolic glutathione reductase in Arabidopsis. Proc Natl Acad Sci U S A 2009; 106(22): 9109-14.
31. Smythe CV. The reactions of Iodoacetate and of Iodoacetamide with various Sulfhydryl groups, with Urease, and with Yeast preparations. J Biol Chem 1936; 114: 601-12.
32. Anson ML. The reactions of Iodine and Iodoacetamide with native Egg Albumin. J Gen Physiol 1940; 23: 321-31.
33. Sharma V, Kalim S, Srivastava MK, Nanda S, Mishra S. Oxidative stress and coxsackievirus infections act as mediators of beta cell damage: a review. SRE 2009; 4 (2): 42-58.
34. Knight JJ. 2-Mercaptoethanol in Encyclopedia of Reagents for Organic Synthesis (Ed: L. Paquette) 2004, J. Wiley & Sons, New York.
35. 2-Mercaptoethanol. Chemicalland21.com. http://www.chemicalland21.com/specialtychem/finechem/2-MERCAPTOETHANOL.htm.
36. Nelson DR, Lehninger AL, Cox M. Lehninger principles of biochemistry. New York: W.H. Freeman. pp. 148, 2005.
37. Material Safety Data Sheet. JT Baker. http://www.jtbaker.com/msds/englishhtml/m1209.htm.
38. Combet C, Jambon M, Deléage G, Geourjon C. Institut de Biologie et Chimie des Protéines, IBCP-CNRS UMR 5086, Pôle Bioinformatique Lyonnais, Bioinformatics and structural NMR, 7, Passage du Vercors, 69 367 Lyon Cedex 07, France.
39. Morris GM, Goodsell DS, Halliday RS, et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function journal. J Comput Chem 1998; 19: 1639-62.
40. Csizmadia F. JChem: Java applets and modules supporting chemical database handling from web browsers. J Chem Inf Comp Sci 2000; 40: 323-4.
41. Nagpal JK, Das BR. Oral cancer: reviewing the present understanding of its molecular mechanism and exploring the future directions for its effective management. Oral Oncol 2003; 39(3): 213-21.
42. Nanda S, Mishra S, Varshney VP, Singh RB. A biotechnological approach to apoptosis of somatic and germ cells in living organisms. Open Nutra J 2010; 3: 81-93.
43. Mishra S, Tyagi A, Dwivedi, SP. Invited Review: Regulation of programmed cell death or apoptosis in living organisms: A biotechnological approach. Biotechnol Bioinf Bioeng 2010; 1: 1-19.
44. Nanda S, Varshney VP, Chauhan N, Srivastava R, Singh RB, Mishra S. Synergistic cytotoxic effect of Syzygium aromaticum extract and gemicitabine on human cervical cancer cell line. J Advance Res Biological Sci 2009; 1(2): 172-81.
45. López-Alonso JP, Bruix M, Font J, et al. NMR spectroscopy reveals that RNase A is chiefly denatured in 40% acetic acid: implications for oligomer formation by 3D domain swapping. J Am Chem Soc 2010; 132: 1621-30.
46. Nelson DR, Lehninger AL, Cox M. Lehninger Principles of Biochemistry. New York: W.H. Freeman. pp. 148, 2005.
47. Ruegg UT, Rudinger J. Cleavage of disulfide bonds in proteins. Methods Enzymol 1997; 47: 111.
48. Duchardt F, Ruttekolk IR, Verdurmen WP, et al. A cell-penetrating peptide derived from human lactoferrin with conformationdependent uptake efficiency. J Biol Chem 2009; 284(52): 36099-108.
49. Mishra S, Dwivedi SP, Dwivedi, Singh RB. Immune response and possible causes of CD4+T-cell depletion in human immunodeficiency virus (HIV) - 1 infection. Open Nutra J 2009; 2: 46-51.